文献速递免疫规划传染病防控与疫情报告

灭活全病毒双价疫苗可诱导针对CVA6和CVA10的平衡保护免疫

Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
PubMed 文献 · Vaccine · 2018-10-11

该研究评价了甲醛灭活全病毒CVA6与CVA10双价联合疫苗的免疫原性和保护效力。小鼠皮下接种可诱导抗原特异性系统免疫应答及多功能性T细胞,使感染新生小鼠保护率超过80%;被动转输免疫血清、母体抗体传递均显示对同型和异型CVA6、CVA10感染及病毒复制的控制作用。

要点

  • 双价疫苗皮下接种诱导抗原特异性系统免疫应答和多功能性T细胞。
  • 主动免疫使感染新生小鼠保护率超过80%。
  • 母体抗体传递对控制同型和异型CVA6、CVA10感染及病毒复制起重要作用。

核心结论

  • 甲醛灭活全病毒CVA6与CVA10双价疫苗在小鼠中可诱导平衡的保护性免疫。
  • 两种抗原在诱导病毒特异性免疫应答方面无免疫干扰,支持多价疫苗开发。

研究设计与样本

  • 研究为小鼠模型实验,评价甲醛灭活全病毒CVA6与CVA10双价联合疫苗的免疫原性和保护效力。

主要发现

  • 双价疫苗皮下接种可诱导抗原特异性系统免疫应答,尤其是多功能性T细胞。
  • 主动免疫在感染新生小鼠中达到超过80%的保护率。
  • 被动转输接种小鼠抗血清可有效保护受体小鼠抵御CVA6和CVA10攻击。
  • 双价疫苗可在成年雌鼠中诱导高水平IgG和中和抗体,母体抗体传递对控制同型和异型CVA6、CVA10感染及体内病毒复制起重要作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coxsackievirus A6 (CVA6) and CVA10 are two of the major pathogens associated with hand, foot and mouth disease (HFMD) in children. The majority of CVA6 and CVA10 infections result in mild, self-limiting episodes (fever and herpangina) in pediatric populations; however, in some cases, can proceed to severe neurological disease and death. Efforts to mitigate viral transmission to decrease the morbidity and mortality associated with infection would be greatly strengthened by the availability of an efficacious CVA6 and CVA10 bivalent vaccine. Here we report the immunogenicity and protective efficacy of a bivalent combination vaccine comprised of formaldehyde-inactivated, whole-virus CVA6 and CVA10. We demonstrate that subcutaneous delivery of the bivalent vaccine can induce antigen-specific systemic immune responses, particularly the induction of polyfunctional T cells, which elicit active immunization to achieve a protection rate of >80% in the infected neonatal mice. Furthermore, passive transfer of the antisera from vaccinated mice potently protected recipient mice against CVA6 and CVA10 challenge. Importantly, the bivalent vaccine could induce high levels of IgG and neutralizing antibodies in adult female mice and the maternal antibody transmitted to the recipient mice played an important role in controlling homotypic and heterotypic CVA6 and CVA10 infections and viral replication in vivo. Collectively, these findings indicate that there is no immunological interference between the two antigens with respect to their ability to induce virus-specific immune responses, and thus provides proof-of-concept for further development of multivalent vaccines for broad protection against HFMD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Dong Z, Wang Q, et al. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice. Vaccine. 2018. PMID: 30316529. doi:10.1016/j.vaccine.2018.09.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。